Cargando…
Small cell carcinoma of the ovary, pulmonary type: A role for adjuvant radiotherapy after carboplatin and etoposide?
BACKGROUND: Primary small cell ovarian cancer of pulmonary type (SCCOPT) remains a rare ovarian tumor. Its aggressive nature is associated with poor survival outcomes. Current treatment algorithms rely on systemic chemotherapy, primarily involving platinum agents. However, given its low incidence, l...
Autores principales: | Asom, Anase S., Lastra, Ricardo R., Hasan, Yasmin, Weinberg, Lori, Fleming, Gini F., Kurnit, Katherine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760400/ https://www.ncbi.nlm.nih.gov/pubmed/35059489 http://dx.doi.org/10.1016/j.gore.2022.100925 |
Ejemplares similares
-
Carboplatin/etoposide: Neutropenia and thrombocytopenia: case report
Publicado: (2021) -
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
por: Thatcher, N., et al.
Publicado: (1989) -
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment
por: Kurnit, Katherine C., et al.
Publicado: (2021) -
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas
por: Kurnit, Katherine C., et al.
Publicado: (2022) -
Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)